Smartphone app could save babies after heart surgery

NCT ID NCT06741189

Recruiting now Disease control Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a home monitoring program can reduce complications and deaths in infants who had heart surgery. Parents will measure their child's heart rate, oxygen levels, and weight at home and send the data daily via a secure app. The program includes alerts for worrisome changes and a team response. 186 children aged 0-36 months will be followed for 6 months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: home monitoring program (heart rate, oxygen, weight tracking via sensors and app)
What this could lead to: If it works, this could reduce serious complications and deaths after heart surgery in infants, and improve quality of life for families.
What could go wrong: This is a relatively small, single-center study. The monitoring may not catch all problems, and families might find it burdensome. Results may not apply to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DEFECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONGENITAL HEART DEFECT

Contacts and locations

Locations

CHU de Nantes
RECRUITING

Nantes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.